Since May this year, new outbreaks of cerebral acne have emerged in many countries in Europe and the United States and spread to the world.
The data shows that more than 16,000 cases of monkey acne have been reported in 75 countries and territories, including 5 deaths in Africa.
This infectious disease has often occurred in west and central Africa in the past.
Elzheimer's reported the country's first confirmed case of monkey acne on the 14th, and the patient arrived in Kerala from the UAE in December. Since then, two more cases of monkey powder disease have been reported in the state.
Experts claim that the monkey-acne virus has undergone many changes.
Australian infectious disease scientists believe that the monkey acne virus that causes large-scale infections has undergone many mutations compared to the monkey acne virus previously circulating in Africa.
Rena McIntyre, an infectious disease scientist at the University of New South Wales in Australia, recently said that the monkey acne virus is a positive comedone virus.
Many European and American countries have reported multiple cases of monkey powder virus clusters, most of which are male sex, and according to WHO, monkey powder incidents occur mainly in West and Central Africa, but there is currently no history of travel from confirmed or suspected cases from multiple countries.
However, WHO notes that in this epidemic, the incidence of some cases is different from before. Outbreaks are likely to continue to spread and surveillance should be strengthened around the world, particularly surveillance of clusters of fever and rashes, as well as varicella, hand-foot-and-mouth, herpes simplex or other rash-related diseases that can inadvertently exacerbate vaccine disputes and lead to wealth in the rich.
He is a Tokyo resident in his 30s who returned from Europe in mid-July. Japan issued a Level 1 infectious disease risk warning and initiated clinical research on medical treatment for treatment and preventive measures, and injected vaccines among front-line medical staff.
On 26 July, WHO Regional Director Punan Singh said in a statement that the risk of outbreaks of monkey powder in Southeast Asia was "moderate", but that the possibility of further international spread was real.
According to the US CDC, at least 76 regions around the world have reported more than 19,000 cases of monkey acne. Most of these occur in non-endemic areas, and a dozen of them are located in the Asia-Pacific region. The latest WHO report shows that more than 70% of confirmed cases are currently confirmed in the European Union and 25% in the Americas. About 10% of patients were hospitalized for treatment of 5 deaths.
WHO recommends vaccinations for health workers and other high-risk groups, and the organization reminds them that they will not be fully protected until weeks after a second dose of the vaccine.
The U.S. National Standard declares that monkey acne is a major infectious disease event in the country.